Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376

Cancer Research

Volumn 59, Issue 16, 1999, Pages 4050-4055

  Valmori, Danila ^a,c   Pittet, Mikaël J ^a   Vonarbourg, Cedric ^a   Rimoldi, Donata ^a   Liénard, Danielle ^a   Speiser, Daniel ^a   Dunbar, Rod ^b   Cerundolo, Vincenzo ^b   Cerottini, Jean Charles ^a   Romero, Pedro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GENE SEQUENCE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOID CELL; MASS SPECTROMETRY; MELANOMA; MOLECULAR CLONING; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; MELANOMA; MONOPHENOL MONOOXYGENASE; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033567024     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Brichard, V. G., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178:489-495, 1993.
2. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K. H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-754, 1994.
3. Rang, X., Kawakami, Y., El-Gamil, M., Wand, R., Sakaguchi, K., Yannelli, J. R., Appella, E., Rosenberg, S. A., and Robbins, P. F. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol., 155: 1343-1348, 1995.
4. Brichaid, V. G., Herman, J., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., and Lethé, B. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol., 26: 224-230, 1996.
5. Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H., and Slingluff, C. L. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J. Immunol., 160: 2099-2106, 1998.
6. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA, 91: 9461-9465, 1994.
7. Kobayashi, H., Kokubo, T., Sat, K., Kimura, S., Asano, K., Takahashi, H., Iizuka, H., Miyokawa, N., and Katagiri, M. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res., 58: 296-301, 1998.
8. Skipper, J. C. A., Hendrickson, R. C., Gulden, P. H., Brichard, V., Van Pel, A., Chen, Y., Shabanowitz, J., Wölfel, T., Slingluff, C. L., Jr., Boon, T., Hunt, D. F., and Engelhard, V. H. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med., 183: 527-534, 1996.
9. Visseren, M. J. W., van Elsas, A., van der Voort, E. I. H., Ressing, M. E., Kast, W. M., Schrier, P. I., and Melief, C. J. M. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol., 154: 3991-3998, 1995.
10. Visseren, M. J. W., van der Burg, S. H., Hawes, G. E., van der Voort, E. I. H., van den Elsen, P. J., and Melief, C. J. M. Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope. Int. J. Cancer, 72: 1122-1128, 1997.
11. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J. L., Liénard, D., Cerottini, J-C., and Cerundolo, V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes. J. Exp. Med., 188: 1641-1650, 1998.
12. Valmori, D., Gervois, N., Rimoldi, D., Fonteneau, J. F., Bonelo, A., Liénard, D., Rivoltini, L., Jotereau, F., Cerottini, J-C., and Romero, P. Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immundominant Melan-A/MART-1 antigenic peptide. J. Immunol., 161: 6956-6962, 1998.
13. Valmori, D., Liénard, D., Waanders, G., Rimoldi, D., Cerottini, J-C., and Romero, P. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res., 57: 735-741, 1997.
14. Valmori, D., Fonteneau, J. F., Marañón Lizana, C., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, C. V., Jotereau, F., Cerottini, J-C., and Romero, P. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J. Immunol., 160: 1750-1758, 1998.
15. van der Burg, S. H., Visseren, M. J. W., Brandt, R. M. P., Kast, W. M., and Melief, C. J. M. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol., 156: 3308-3314, 1996.
16. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science (Washington DC), 274: 94-96, 1996.
17. Madden, D. R., Garboczi, D. N., and Wiley, D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell, 75: 693-708, 1993.
18. Valmori, D., Pittet, M. J., Rimoldi, D., Liénard, D., Dunbar, R., Cerundolo, V., Lejeune, F., Cerottini, J-C., and Romero, P. An antigen targeted approach to adoptive transfer therapy of cancer. Cancer Res., 59: 2167-2173, 1999.
19. Mosse, C. A., Meadows, L., Luckey, C. J., Kittlesen, D. J., Huczko, E. L., Slingluff, C. L., Jr., Shabanowitz, J., Hunt, D F., and Engelhard, V. H. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med., 187: 37-48, 1998.
20. Seite, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., Del Guercio, M. F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., and Chisari, F. V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol., 153: 5586-5592, 1994.
21. Jaeger, E., Ringhoffer, M., Arand, M., Karbach, J., Jaeger, D., Ilsemann, C., Hagendorn, M., Oesch, F., and Knuth, A. Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res., 6: 419-425, 1996.
22. Ogg, G. S., Dunbar, P. R., Romero, P., Chen, J., and Cerundolo, V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med., 188: 1203-1208, 1998.
23. Bystrin, J. C., Darrell, R., Friedman, R. J., and Kopf, A. Prognostic significance of hypopigmentation in malignant melanoma. Arch. Dermatol., 123: 1053-1055, 1987.